Cite

Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive <italic>INS</italic> gene mutation.

MLA

Yildiz, Melek, et al. “Emergence of Insulin Resistance Following Empirical Glibenclamide Therapy: A Case Report of Neonatal Diabetes with a Recessive INS Gene Mutation.” Journal of Pediatric Endocrinology & Metabolism, vol. 31, no. 3, Mar. 2018, pp. 345–48. EBSCOhost, https://doi.org/10.1515/jpem-2017-0325.



APA

Yildiz, M., Akcay, T., Aydin, B., Akgun, A., Dogan, B. B., De Franco, E., Ellard, S., & Onal, H. (2018). Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation. Journal of Pediatric Endocrinology & Metabolism, 31(3), 345–348. https://doi.org/10.1515/jpem-2017-0325



Chicago

Yildiz, Melek, Teoman Akcay, Banu Aydin, Abdurrahman Akgun, Beyza Belde Dogan, Elisa De Franco, Sian Ellard, and Hasan Onal. 2018. “Emergence of Insulin Resistance Following Empirical Glibenclamide Therapy: A Case Report of Neonatal Diabetes with a Recessive INS Gene Mutation.” Journal of Pediatric Endocrinology & Metabolism 31 (3): 345–48. doi:10.1515/jpem-2017-0325.